Award
National Cancer Institute 2R01CA190394-11A1
Targeting the cytokine circuitry of KRAS driven lung cancer
Recipient
David A Barbie
Award Amount
$460,600.00
Ceiling
$460,600.00
Awarded
April 06, 2026
Identifier
2R01CA190394-11A1
NIH grant awarded to support research on immune response and therapeutic strategies for KRAS-driven lung cancer, focusing on innate immune signaling pathways and novel clinical approaches.
Description
This NIH grant supports research on the immune response and therapeutic strategies targeting KRAS-driven lung cancer, focusing on innate immune signaling pathways, including STING-IFN signaling, TREX1, and PARP7 inhibitors. The project aims to develop novel approaches for clinical translation.